Test my supply
63%
Finnrick rating
#244 of 301 ranked vendors
7 of 15 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Amino Asylum's purity-focus record is strongest on Semaglutide and Melanotan II, while the wider catalog is dispersed rather than showing a clean upward pattern. BPC-157 and CJC-1295 are the clearest weak spots, and sparse, close-dated testing with missing batch IDs and fill swings limits confidence.

methodology →
vendor intelligence report
Vendor Intelligence Report: Amino Asylum

The investigation traces Amino Asylum traffic into a Soma Chems successor route through redirects, reused address records, and GymNTonic labeling. It also maps Delaware no-record searches, affiliate-code promotion, FDA-raid reporting, and clone-risk channels.

28 pages7 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$25.00
78%
2
2
Retatrutide
$35.00
77%
2
3
Semaglutide
$25.00
72%
2
4
Ipamorelin
$10.00
68%
2
5
Melanotan II
$3.00
65%
2
6
PT-141
$5.00
58%
1
7
BPC-157
$7.00
46%
2
8
CJC-1295
$12.50
25%
2
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%14 Feb 2025: 79%14 Feb 2025: 70%14 Feb 2025: 64%19 Feb 2025: 57%19 Feb 2025: 51%19 Feb 2025: 53%19 Feb 2025: 52%19 Feb 2025: 53%19 Feb 2025: 54%19 Feb 2025: 54%19 Feb 2025: 55%19 Feb 2025: 55%19 Feb 2025: 55%21 Feb 2025: 54%16 Mar 2025: 51%10 Aug 2026: current 63%79%63%Feb 25Aug 26
Test my supply
Amino Asylum test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
16 Mar 2025Fail
PT-141
lab nameView COA
21 Feb 2025Fail
CJC-1295 (No DAC)
lab nameView COA
19 Feb 2025Pass
Melanotan II
lab nameView COA
19 Feb 2025Fail
BPC-157
lab nameView COA
19 Feb 2025Pass
Retatrutide
lab nameView COA
19 Feb 2025Pass
Ipamorelin
lab nameView COA
19 Feb 2025Fail
Ipamorelin
lab nameView COA
19 Feb 2025Pass
Melanotan II
lab nameView COA
19 Feb 2025Fail
CJC-1295 (No DAC)
lab nameView COA
19 Feb 2025Fail
BPC-157
lab nameView COA
1-10 of 15

About Amino Asylum test results from Finnrick

Amino Asylum is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 15 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Amino Asylum peptides in this dataset are Tirzepatide (2 tests) and Retatrutide (2 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 15 recent tests.

Corrections
No corrections.
Test my supply